What is the current price for "Will the FDA approve any psychedelic substance for medical use before 2027?"?

The leading outcome "No" is currently trading at 60.5% probability.

How many markets are available for "Will the FDA approve any psychedelic substance for medical use before 2027?"?

There are 1 markets available for this event on Kalshi.

What is the trading volume for "Will the FDA approve any psychedelic substance for medical use before 2027?"?

Total trading volume is approximately $41K.

PredictPedia

Markets Wiki

Will the FDA approve any psychedelic substance for medical use before 2027? | PredictPedia

BackKKALSHI

Will the FDA approve any psychedelic substance for medical use before 2027?

Yes40%

Vol$40.95K

Markets1

40%

TradeTrade on Kalshi

Event Group

EventKALSHI

Single EventKALSHIHealth

Will the FDA approve any psychedelic substance for medical use before 2027?

Name: Will the FDA approve any psychedelic substance for medical use before 2027?
Start: 2026-01-16T14:09:53.346Z
End: 2026-02-15T14:09:53.346Z

Part of: Will the FDA approve any psychedelic substance for medical use before 2027?

Before 2027 If the FDA approves Any psychedelic substance for medical use for marketing before Jan 1, 2027, then the market resolves to Yes. Psychedelic drugs include: LSD, Psilocybin, DMT, Mescaline, MDMA, MDA,, PCP, DXM, Ibogaine, Salvia divinorum, 2C family, and Ayahuasca. This market will close and expire early if the event occurs.

YesLeading Yes Probability

40%

VolTotal Volume

$40.95K

Markets

Trade on Kalshi

Will the FDA approve any psychedelic substance for medical use before 2027?

Yes

40%

Vol

$40.95K

Markets

Trade

Market Price Graph

1 market tracked

Will the FDA approve Any psychedelic substance for medical use this year?

kalshi

No data available

All Markets(1)

Market	Price
Will the FDA approve Any psychedelic substance for medical use this year?	40%

Markets (1)

Sort

KALSHIHealth

Will the FDA approve Any psychedelic substance for medical use this year?

If the FDA approves Any psychedelic substance for medical use for marketing before Jan 1, 2027, then the market resolves to Yes. Secondary rules: Psychedelic drugs include: LSD, Psilocybin, DMT, Mescaline, MDMA, MDA,, PCP, DXM, Ibogaine, Salvia divinorum, 2C family, and Ayahuasca. Early close condit